Reliq Health Technologies, Inc. Announces New Contract with a Large US Health Plan
16 Maio 2023 - 4:01AM
Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or
WKN:A2AJTB) (“
Reliq” or the
“
Company”), a rapidly growing global healthcare
technology company that develops innovative Virtual Care solutions
for the multi-billion dollar Healthcare market, is pleased to
announce that it has signed a new contract with a large US Health
Plan. The health plan operates Accountable Care Organizations
(ACOs) in five States with over 3,000 doctors and more than
1,000,000 patients. Onboarding with this new client will begin in
July with one of their ACOs in Texas, which is expected to add over
10,000 new patients to Reliq’s iUGO Care platform by the end of
March 2024 at an average revenue of $65 per patient per month.
“We are very pleased to have signed our first
contract with a US Health Plan,” said Dr. Lisa Crossley, CEO at
Reliq Health Technologies, Inc. “This new client is a proactive
healthcare organization that works to improve health outcomes while
also reducing healthcare spending. The client operates large
Accountable Care Organizations (ACOs), which are groups of
healthcare providers who work together under a value-based care
model to reduce healthcare costs and improve quality of care. The
ACOs in this client’s network include over 3,000 physicians and
serve more than a million patients. The Remote Patient Monitoring,
Chronic Care Management and Behavioral Health Integration solutions
Reliq will be providing using our iUGO Care platform will support
critical preventative programs to assist the ACOs in achieving
their cost and quality of care objectives. The client is a
subsidiary of one of the nation’s largest providers of hospital and
healthcare services and a Fortune 500 Company, and is focused on
community-based primary care, post-acute and specialty care. We
will initially begin deploying our iUGO Care platform with one of
the plan’s ACOs in Texas. We expect to add over 10,000 patients
from this ACO to the iUGO Care platform by the end of March 2024,
at an average of $65 per patient per month with an expected 75%
gross margin. This new contract is further validation of Reliq’s
unique value proposition in the US healthcare market and clearly
demonstrates our rapidly accelerating traction with large,
multi-state US healthcare organizations.”
Reliq Health
Reliq Health Technologies is a rapidly growing
global healthcare technology company that specializes in developing
innovative Virtual Care solutions for the multi-billion dollar
Healthcare market. Reliq’s powerful iUGO Care platform supports
care coordination and community-based virtual healthcare. iUGO Care
allows complex patients to receive high quality care at home,
improving health outcomes, enhancing quality of life for patients
and families and reducing the cost of care delivery. iUGO Care
provides real-time access to remote patient monitoring data,
allowing for timely interventions by the care team to prevent
costly hospital readmissions and ER visits. Reliq Health
Technologies trades on the TSX Venture under the symbol RHT, on the
OTC as RQHTF and on the Frankfurt Stock Exchange under the
WKN:A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company ContactInvestor Relations
at ir@reliqhealth.com
US Investor Relations ContactInvestor
RelationsLytham Partners, LLCBen ShamsianNew York |
Phoenix646-829-9701shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward
Looking Information
Certain statements in this press release
constitute forward-looking statements, within the meaning of
applicable securities laws. All statements that are not historical
facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives,
assumptions, expectations or beliefs of future performance, are
"forward-looking statements".
We caution you that such "forward-looking
statements" involve known and unknown risks and uncertainties that
could cause actual and future events to differ materially from
those anticipated in such statements.
Forward-looking statements include, but are not
limited to, statements with respect to commercial operations,
including technology development, anticipated revenues, projected
size of market, and other information that is based on forecasts of
future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the
"Company") does not intend and does not assume any
obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology
development and marketing activities, the Company's historical
experience with technology development, uninsured risks. Actual
results may differ materially from those expressed or implied by
such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies (TSXV:RHT)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Reliq Health Technologies (TSXV:RHT)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024